| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5988697 | The Journal of Thoracic and Cardiovascular Surgery | 2015 | 26 Pages |
Abstract
Induction chemoradiation is used in the majority of patients with non-small cell lung cancer with N2 disease who undergo induction therapy before surgical resection, but it is not associated with improved survival compared with induction chemotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chi-Fu Jeffrey MD, Brian C. MD, Lin MS, Paul J. MD, Xiaofei PhD, David H. MD, Mark W. MD, Thomas A. MD, Mark F. MD, MHS, Matthew G. MD,